All Stories

  1. Bronchoalveolar lavage for supporting acute cellular rejection in lung transplant recipients: A retrospective analysis
  2. ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD): Definition, Etiology, Diagnostic and Therapeutic Approaches, and Research Priorities
  3. Donor-recipient sex differences: Implications for immunologic outcomes but no impact on survival after lung transplantation
  4. Correlation between acute cellular rejection detected with cryobiopsy and elevated donor-derived cell-free DNA in lung transplant recipients
  5. Management of microaspiration and gastrointestinal dysfunction after lung transplantation: A narrative review
  6. Tacrolimus overdosing in lung transplant recipients: clinical manifestations and management
  7. Coronavirus infection and chronic lung allograft dysfunction: a retrospective cohort study
  8. Transbronchial cryobiopsy alone versus combined with traditional forceps biopsy for acute cellular rejection in lung transplant recipients. A diagnostic randomized trial
  9. Neutrophil-to-lymphocyte ratio as a prognostic marker for lung cancer in combined pulmonary fibrosis and emphysema patients
  10. Low agreement and frequent invalid controls in two SARS-CoV-2 T-cell assays in people with compromised immune function
  11. Clinical characteristics and outcomes in patients with Anti-MDA5 positive interstitial lung disease: A case series from a lung transplant center
  12. Combined pulmonary fibrosis and emphysema and lung transplantation: current evidence and future directions
  13. Transbronchial forceps- and cryobiopsy for detecting acute cellular rejection in lung transplant recipients: A randomised trial
  14. Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study
  15. 263.11: ACR detected with cryobiopsy in lung transplant recipients is not associated with elevated dd-cfDNA.
  16. P.041: Switching from ciclosporin to tacrolimus as de novo calcineurin inhibitor in lung transplantation: First results of a multidisciplinary quality assurance project.
  17. Blickdiagnose für Fortgeschrittene
  18. Antibody and T-Cell Response to Bivalent Booster SARS-CoV-2 Vaccines in People With Compromised Immune Function: COVERALL-3 Study
  19. Early extracorporeal photopheresis treatment is associated with better survival in patients with chronic or recurrent acute lung allograft dysfunction
  20. mTOR inhibitors after lung transplantation: a real-life experience
  21. Association between anion gap and the 30-day mortality of patients with ventilator-associated pneumonia: a study of the MIMIC-III database
  22. Controlled Donation After Circulatory Death Lung Transplantation in University Hospital Zurich: 10-years' Experience
  23. Indirect Recognition HLA Score as a Predictor of CLAD In Lung Transplant
  24. Pretransplant management of coexisting diseases
  25. Frailty as a Prognostic Indicator in Lung Transplantation: A Comprehensive Analysis
  26. Impact of SARS-CoV-2-Related Hygiene Measures on Community-Acquired Respiratory Virus Infections in Lung Transplant Recipients in Switzerland
  27. Improved glucose tolerance after initiation of Elexacaftor / Tezacaftor / Ivacaftor in adults with cystic fibrosis
  28. Multimodal Remote Home Monitoring of Lung Transplant Recipients during COVID-19 Vaccinations: Usability Pilot Study of the COVIDA Desk Incorporating Wearable Devices
  29. Adaptive Immunosuppression in Lung Transplant Recipients Applying Complementary Biomarkers: The Zurich Protocol
  30. COVID-Related Chronic Allograft Dysfunction in Lung Transplant Recipients: Long-Term Follow-up Results from Infections Occurring in the Pre-vaccination Era
  31. Influence of mycophenolate mofetil dosage and plasma levels on the occurrence of chronic lung allograft dysfunction in lung transplants.
  32. Influence of mycophenolate mofetil dosage and plasma levels on the occurrence of chronic lung allograft dysfunction in lung transplants: a retrospective cohort analysis
  33. COVID-19-Associated Lung Fibrosis: Two Pathways and Two Phenotypes, Lung Transplantation, and Antifibrotics
  34. Transbronchial Cryobiopsy Compared to Forceps Biopsy for Diagnosis of Acute Cellular Rejection in Lung Transplants: Analysis of 63 Consecutive Procedures
  35. COVID-19-related end stage lung disease: two distinct phenotypes
  36. Clinical Characteristics, Treatments and Outcomes of 18 Lung Transplant Recipients with COVID-19
  37. Transbronchial Cryobiopsy Compared to Forceps Biopsy for Diagnosis of Acute Cellular Rejection in Lung Transplant Recipients
  38. Combined Pulmonary Fibrosis and Emphysema (CPFE) Clinical Features and Management
  39. Cyclosporine A and COVID-19 – The COQUIMA cohort
  40. P137 COVID-19 in cystic fibrosis patients with and without lung transplantation: the Zurich cohort
  41. Clinical Aspects of COVID-19 in Patients with Solid Organ Transplantation: A Systematic Review
  42. COVID-19 in solid organ transplant recipients
  43. Transplant Drugs against SARS, MERS and COVID-19
  44. Vaping-assoziierte Lungenerkrankung «VAPI»
  45. Work Reintegration after Lung Transplantation: A Complex and Multifaceted Topic
  46. Calcineurin Inhibitors and COVID-19
  47. Electronic cigarettes and vaping associated pulmonary illness (VAPI): A narrative review
  48. Calcineurin inhibitors revisited: A new paradigm for COVID-19?
  49. Suggested management of e-cigarette or vaping product use associated lung injury (EVALI)
  50. SARS-CoV-2 and Norovirus Co-Infection after Lung Transplantation
  51. COVID-19 in Patients with Solid Organ Transplantation: A Systematic Review
  52. Malaria-associated pulmonary edema
  53. Rapid review: sinonasal surgery vs. medical therapy for asthma in patients with chronic rhinosinusitis with or without nasal polyps
  54. Accuracy of symptoms, signs, and C-reactive protein for early chronic obstructive pulmonary disease
  55. Large-cell neuroendocrine carcinoma (LCNC) of the lung: a dilemma
  56. Update in Pulmonary Carcinoid Tumors: A Review Article
  57. Pulmonary large-cell neuroendocrine carcinoma (LCNEC)
  58. Primitive neuroectodermal tumor: Report of two cases and review of the literature
  59. Neural Cell Adhesion Molecule Expression
  60. Neo-adjuvant chemotherapy followed by surgery and/or radiotherapy in patients with stage IIIB non-small cell lung cancer (NSCLC), preliminary data
  61. Surgery for combined type small cell lung carcinoma
  62. Detection of flow limitation during tidal breathing by the interruptor technique